Forecast: Prostate Cancer.
By Joseph Hedden, Senior Analyst
7 January 2016
I am an analyst at Datamonitor Healthcare, having previously completed a PhD in Structural and Molecular Biology at Univ...
Read full bio
Datamonitor Healthcare is foreseeing strong growth in the prostate cancer drug market with the value of the market forecasted to double in the US, Japan and major EU markets during 2015-24. This report will provide you with an in depth analysis of how the market will change and how this change could affect you and your business.
Our latest prostate cancer 10 year forecast will enable you to:
> Delve into the prostate cancer market, enabling you to get a granular view of the impact that key events will have on specific brands.
> Stay ahead of your competitors by understanding how market dynamics will change, so you can effectively adapt your strategy.
> Understand the drivers and resistors of market growth in order to take advantage of opportunities in this market.
Explore our prostate cancer forecast by downloading your exclusive extract from this market leading report >>
If you’re already a subscriber to Datamonitor Healthcare, click here to access the full report.